• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Peptic Ulcer Partnering 2009-2014 Product Image

Peptic Ulcer Partnering 2009-2014

  • ID: 2208456
  • November 2014
  • Region: Global
  • 100 pages
  • CurrentPartnering

FEATURED COMPANIES

  • Abbott
  • Baxter International
  • Dainippon Sumitomo
  • Grifols
  • Mitsubishi Tanabe
  • Servier
  • MORE

The Peptic Ulcer Partnering 2009-2014 report provides understanding and access to the peptic ulcer partnering deals and agreements entered into by the worlds leading healthcare companies.

- Trends in peptic ulcer partnering deals
- Top peptic ulcer deals by value
- Deals listed by company A-Z, industry sector, stage of development, technology type

The Peptic Ulcer Partnering 2009-2014 provides understanding and access to the peptic ulcer partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of peptic ulcer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors peptic ulcer technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Baxter International
  • Dainippon Sumitomo
  • Grifols
  • Mitsubishi Tanabe
  • Servier
  • MORE

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in peptic ulcer partnering

2.1. Introduction
2.2. Peptic ulcer partnering over the years
2.3. Big pharma peptic ulcer dealmaking activity
2.4. Big biotech peptic ulcer dealmaking activity
2.5. Most active peptic ulcer dealmakers
2.6. Peptic ulcer partnering by deal type
2.7. Peptic ulcer partnering industry sector
2.8. Peptic ulcer partnering by stage of development
2.9. Peptic ulcer partnering by technology type
2.10. Disclosed financial deal terms for peptic ulcer
2.10.1 Peptic ulcer headline values
2.10.2 Peptic ulcer upfront payments
2.10.3 Peptic ulcer milestone payments
2.10.4 Peptic ulcer royalty rates

Chapter 3 – Leading peptic ulcer deals

3.1. Introduction
3.2. Top peptic ulcer deals by value

Chapter 4 – Dealmaking directory

4.1. Introduction
4.2. Company A-Z
4.3. By deal type
4.4. By industry sector
4.5. By stage of development
4.6. By technology type

Chapter 5 – Partnering resource center

5.1. Online partnering
5.2. Partnering events
5.3. Further reading on dealmaking

Appendices

Appendix 1 – Deal type definitions

Recent report titles from
Order Form – Subscription Access Products

Table of figures

Figure 1: Peptic ulcer partnering since 2009
Figure 2: Big pharma – top 50 – peptic ulcer deals 2009 to 2014
Figure 3: Big pharma peptic ulcer deal frequency – 2009 to 2014
Figure 4: Big biotech – top 50 – peptic ulcer deals 2009 to 2014
Figure 5: Big biotech peptic ulcer deal frequency – 2009 to 2014
Figure 6: Peptic ulcer dealmaking activity– 2009 to 2014
Figure 7: Peptic ulcer partnering by deal type since 2009
Figure 8: Peptic ulcer partnering by industry sector since 2009
Figure 9: Peptic ulcer partnering by stage of development since 2009
Figure 10: Peptic ulcer partnering by technology type since 2009
Figure 11: Peptic ulcer deals with a headline value
Figure 12: Peptic ulcer deals with upfront payment values
Figure 13: Peptic ulcer deals with milestone payments
Figure 14: Peptic ulcer deals with royalty rates, %
Figure 15: Top peptic ulcer deals by value since 2009
Figure 16: Online partnering resources
Figure 17: Forthcoming partnering events
Figure 18: Deal type definitions

Note: Product cover images may vary from those shown

Abbott
Actavis
Actelion
Allergan
Amgen
Aspen Pharmacare
Astellas
AstraZeneca
Baxter International
Bayer
Biogen Idec
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
CSL
Daiichi Sankyo
Dainippon Sumitomo
Eisai
Eli Lilly
Endo Pharmaceuticals
Forest Laboratories
Galderma
Gilead Sciences
GlaxoSmithKline
Grifols
Hospira
Johnson & Johnson
Kyowa Hakko Kirin
Lundbeck
Menarini
Merck & Co
Merck KGaA
Mitsubishi Tanabe
Novartis
Novo Nordisk
Otsuka
Pfizer
Purdue
Roche
Sanofi
Servier
Shionogi
Shire
Takeda
Teva
Valeant
Warner Chilcott
Watson

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos